Eurofins CDMO Alphora is developing and launching AI-powered software for high-throughput salt and co-crystal screening. According to the company, such screening has evolved into being a core component of all solid-state screening programs.

Part of the international Eurofins Scientific network, Eurofins CDMO Alphora operates in Mississauga, Ontario, Canada. It is there, the company said, that it developed the new machine learning platform, in partnership with a local university.

Details of the AI Software

The platform, according to the company, accurately predicts salt and co-crystal formation for active pharmaceutical ingredients (APIs) and intermediates. Eurofins CDMO Alphora’s solid-state R&D team guides customers through each stage of salt and co-crystal development.

Among that which the advanced predictive technology achieves is streamlining solid form selection, in several different ways. These include minimizing trial and error experimentation, shortening timelines in development, and lowering costs of screening.

With regard to the interface of the platform, it is considered user-friendly, and empowers clients to make smarter decisions that are more data-driven. In the drug development process, this ultimately results in faster and more efficient delivery of optimized solid forms.

Other Eurofins CDMO Alphora News

The year 2026, though not even a month old, carries a good amount of anticipation for Eurofins CDMO Alphora. Previously, in September 2024, the company unveiled its plans to build a good manufacturing practice (GMP) biologics manufacturing facility in Mississauga. At the time of that announcement, completion of construction was scheduled for this spring.

The 50,000-square-foot facility, housed within a 112,000-square-foot building on a 14-acre campus, has numerous distinct features. It will be equipped to the 2000L bioreactor scale and employ single-use technology, Additionally, it will be capable of running both fed-batch and perfusion modes.

The completion of this facility follows that of a development and pilot scale-up facility. That building launched operations two years ago, in January 2024. Altogether, Eurofins CDMO Alphora’s expansion plans enhance the company’s strategic vision of a suite of integrated solutions.